Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Department of Defense award for vaccine technology development at Generex

Feb. 3, 2004

Photodynamic therapy in combination with DMXAA shows promising therapeutic advantages

Feb. 3, 2004

Pfizer team presents novel GnRH antagonists in a recent patent

Feb. 3, 2004

Merck presents novel KSP inhibitors with utility in cancer therapy

Feb. 3, 2004

Cerus acquires mesothelin rights from Johns Hopkins University

Feb. 2, 2004

New phase I trial for RSR-13 in locally advanced NSCLC

Feb. 2, 2004

Bevacizumab inhibits tumor vascularity

Feb. 2, 2004

Exelixis scientists present new antiangiogenic ADAM-10 inhibitors

Feb. 2, 2004

Antitumor effects reported for erlotinib in metastatic head and neck cancer

Feb. 2, 2004

Xcytrin enters phase I trial in combination with Temodar for glioma

Jan. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026